newsfilter
← Latest News
GlobeNewswire·

Intercept to Announce Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023

MORRISTOWN, N.J., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive